MTP moving in to long-term down trend resistance, should see significant upside when it breaks.
low float stock, reverse split on March . Please note: I'm just sharing my view. its not a recommendation for buying or selling
Personally, the potential of this stock is yuge as long as the price action adheres to the cypher patterns and fib levels. MTP at the moment is acting like a big fish; patience is key to bring in the prize. Appears to be in consolidation phase and the squeeze will continue over the next weeks. A great time to buy and prep for the next steps. The Gann Fan shows...
MTP and FLOOF are trending up with the same patterns - a bearish cypher - a bullish cypher - both of the above are within a larger cypher MTP appears to have greater potential for gains. This post shows the big picture; will follow with a more detailed view.
This company has an interesting pipeline ahead of it, and several undisclosed partners for some of their drugs under their Q-Sphera technology. From a pure technical chart analysis, we can expect some huge swings in the near future. www.midatechpharma.com Disclaimer: This written/visual material is comprised of personal opinions and ideas.
Enter on Pullback to 2.1 Target1: 3 Target2: 4
Higher price rejection after spike and gap up Following a similar pattern in july. May want to fill the gap yet again If confirmed PT1 = 2,61 PT2 = 2,02
Midatech Pharma PLC Announces Registration Statement Declared Effective has declared effective the Company's registration statement on Form F-1 (the "Registration Statement") relating to the permitted resale of up to 12,695,445 ordinary shares, nominal value 0.1p each, in the Company ("Ordinary Shares") represented by 2,539,091 American Depositary Shares (the...
Price rejection after spike up PM down 10% already Could fill the gap down. PT1 = 3,33 PT2 = 2,77 PT3 = 2,26 PT4 = 1,85 Bonus PT5 = 1,18
Midatech Pharma PLC announces Collaboration for the Q-Sphera platform announces it has entered into a research collaboration for the Q-Sphera platform with a European affiliate of a global pharmaceutical company. Midatech Pharma's next generation drug delivery technologies to be applied to new modalities in collaboration with a European pharmaceutical...
Awaiting a possible breakout above the 200ma Huge upside potential Company Profile Midatech Pharma Plc commercializes oncology treatments and cancer supportive care products through its U.S. commercial organization, Midatech Pharma US. The company engages in the development of pharmaceutical products utilizing its nanomedicine and sustained release...
Because nobody else will dare chart this.
MTP has reached another all time low and is currently printing a double bullish divergence on the weekly chart. The chart is searching for a support level which was established last week between .72 and .73 cents a share. The divergence indicator is flashing a buy signal in this acummulation zone between .72 and .79 cents, similarly to how it did on the last big...
$MPT **Alert, Looking for Entery-10%-12% Profit Target, Keep stops close
MTP = DAILY = WEDGE LOW = EXPLOSION = PULL BACK Long from 0.48 S tp1 0.65 $ tp2 0.85 $ tp3 1 $